Molecular alteration patterns were a better predictor of aggressive tumor behavior than tumor size in papillary thyroid carcinoma.

Upper urinary tract urothelial carcinoma (UTUC) is categorised into low-risk (LR) and high-risk (HR) groups based on patient ...

Dr. Huang concluded this presentation discussing results of a phase II study of tislelizumab as neoadjuvant treatment for cisplatin-ineligible high-risk upper tract urothelial carcinoma with the ...

Long-term data from QUILT-3.032 showed that NAI plus BCG shows sustained responses in BCG-unresponsive bladder cancer with 84 ...

for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...

Papillary renal cell carcinoma is a type of kidney cancer. The kidneys are two small organs that work to remove waste products from the blood. Papillary renal cell carcinoma (PRCC) forms in the cells ...

FNA is recommended for all palpable solitary or dominant nodules, independent of size. FNA is preferred over thyroid scan or ultrasonography as the initial diagnostic test for thyroid nodules ...

Background There is no clinically relevant serological marker for the early detection of oesophageal adenocarcinoma (EAC) and its precursor lesion, Barrett’s oesophagus (BE). Objective To develop and ...

Adrenal carcinoma is a rare form of cancer that occurs when healthy cells in the adrenal glands mutate and grow out of control. The adrenal glands are two small organs located above each of the ...

By combining the analysis of active enhancer profiles and genomic structural variation, a lineage-specific super enhancer for MYB in gastrointestinal adenocarcinoma was discovered and validated.